Aikawa T
Department of Internal Medicine, Sagamihara National Hospital.
Nihon Rinsho. 1994 Aug;52(8):2103-8.
Malignant rheumatoid arthritis (MRA) is designated as rheumatoid arthritis with vasculitis, but MRA is commonly called rheumatoid vasculitis in western countries. Patients with MRA show a variety of symptoms and signs based on vasculitis. The clinical features include subcutaneous nodule, skin ulcer, pericarditis, myocarditis, pleuritis, pneumonitis, intestinal infarction, mononeuritis multiplex and other involvements. The cause of the various vascular lesions in MRA has not been clearly defined, but a number of observations suggest that they result from injury induced by immune complexes, especially, those containing rheumatoid factor (RF). The theory of self-associated IgG RF has been proposed. MRA is usually treated with steroid, and steroid pulse therapy and immunosuppressants are highly useful for severe MRA.
恶性类风湿关节炎(MRA)被定义为伴有血管炎的类风湿关节炎,但在西方国家,MRA通常被称为类风湿血管炎。MRA患者会出现基于血管炎的各种症状和体征。临床特征包括皮下结节、皮肤溃疡、心包炎、心肌炎、胸膜炎、肺炎、肠道梗死、多发性单神经炎及其他受累情况。MRA中各种血管病变的病因尚未明确,但一些观察结果表明,它们是由免疫复合物,尤其是含有类风湿因子(RF)的免疫复合物诱导的损伤所致。已经提出了自身相关IgG RF理论。MRA通常用类固醇治疗,类固醇脉冲疗法和免疫抑制剂对重症MRA非常有效。